1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends
  5. > Global Alpha Emitters Market

Global Alpha Emitters Market

  • December 2016
  • -
  • Mordor Intelligence LLP
  • -
  • 67 pages

The global market for alpha emitters has been estimated at $XX million for the year 2014 and is projected to reach $XX million by 2021 at a CAGR of XX% during the forecast period 2016 to 2021. Alpha emitters are radioactive substances that decay after emitting alpha particles. Alpha emitter radionuclide is considered to be a new approach to treat many cancer types. Alpha-particles offer specific tumor cell killing action causing less damage to surrounding normal tissues than beta-emitters and this potential has caught market attention.

The targeted delivery of alpha emitter labeled radionuclides are being used to treat glioblastoma, ovarian cancer, lymphoma, melanoma, pancreatic cancer, gastric cancer, breast cancer, bone Metastasis and bladder cancer. Alpha emitter therapy holds a great promise when compared to chemotherapy as targeted alpha therapy allows easy discrimination between the healthy cells and cancer cells. The end-users of this market are usually Hospital, Imaging centers and research laboratories.

Increasing incidences of cancer, the therapeutic efficacy of alpha-emitter radionuclides and increased awareness about the potential benefits of targeted alpha therapy are the factors driving this market. Whereas, the lack of widespread availability of alpha-emitters, concerns regarding the potential toxicity of these agents, shorter life of radiopharmaceuticals, need for high capital investment, stringent regulatory framework and reimbursement issues are the major factors impacting market growth.

Alpha Emitters market can be segmented on basis of Radionuclide Types which include Terbium (Tb-149), Astatine (At-211), Bismuth (Bi-212), Bismuth (Bi-213), Actinium (Ac-225), Radium (Ra-223), Lead (Pb-212) and others.

Based on geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. Developing countries like India hold strong market potential for alpha emitter therapy. Europe has large number of alpha emitter therapeutic procedures than North America, thereby, European market dominates the American market.

Many players in this market are trying to expand their product portfolio in order to top the global market. While few companies are entering into the market by acquisitions, top companies are expanding their growth in this market by acquiring other companies. Few companies adopted product innovation and new product launches as its key business strategy to ensure its dominance in this market. Major players in the market are Mallinckrodt, Lantheus medical imaging, IBA Group, Traid Isotope, Siemens Healthcare and NTP Radioisotopes.

Key Deliverables in the Study

Market analysis for the Global Alpha Emitters Market, with region specific assessments and competition analysis on global and regional scales
Market definition along with the identification of key drivers and restraints
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale
Extensively researched competitive landscape section with profiles of major companies along with their market shares
Identification and analysis of the macro and micro factors that affect the Global Alpha Emitters Market on both global and regional scales
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

Table Of Contents

Global Alpha Emitters Market
1. Executive Summary

2. Introduction

2.1 Report Description

2.2 Research Methodology

3. Market Overview

3.1 Market Segmentation

3.2 Market Drivers

3.2.1 Increasing incidences of cardiac and cancer ailments

3.2.2 Increased awareness about the potential benefits of targeted alpha therapy

3.2.3 Ready availability of radiopharmaceuticals

3.3 Market Restraints

3.3.1 Shorter half-life of radiopharmaceuticals

3.3.2 Need for high capital investment

3.3.3 Stringent regulatory framework

3.3.4 Reimbursement issues

3.4 Market Opportunities

3.5 Market Threats

4. Porters Five Force Analysis

4.1 Bargaining Power of Suppliers

4.2 Bargaining Power of Buyers

4.3 Internal Rivalry

4.4 Threat of Substitution

4.5 Threat of New Entrants

5. Global Alpha Emitters Market Segmentation

5.1 Segmentation by Type of Radionuclide

5.1.1 Terbium (Tb-149)

5.1.2 Astatine (At-211)

5.1.3 Bismuth (Bi-212)

5.1.4 Actinium (Ac-225)

5.1.5 Radium (Ra-223)

5.1.6 Lead (Pb-212)

5.1.7 Bismuth (Bi -213)

5.1.8 Others

5.2 Segmentation by Medical Application

5.2.1 Glioma

5.2.2 Melanoma

5.2.3 Pancreatic Cancer

5.2.4 Ovarian Cancer

5.2.5 Thyroid

5.2.6 Bone Metastasis

5.2.7 Lymphoma

5.2.8 Endocrine Tumors

5.2.9 Others

5.3 Segmentation by Geography

5.3.1 North America US Canada

5.3.2 Europe UK Germany France Sweden Finland Norway Netherlands Spain Italy Others

5.3.3 Asia Pacific China Japan South Korea India Australia Others

5.3.4 Middle East and Africa Saudi Arabia UAE South Africa Others

5.3.5 Latin America Brazil Argentina Mexico Others

6. Competitive Landscape

6.1 Mergers and Acquisitions

6.2 Collaborations, Agreements, and Partnerships

6.3 New Product Launches

7. Company Profiles

7.1 IBA Group

7.2 Lantheus Medical Imaging

7.3 Triad Isotopes

7.4 Siemens Healthcare (PETNET Solutions)

7.5 NTP Radioisotopes

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Radiopharmaceuticals: Technologies and Global Markets

Radiopharmaceuticals: Technologies and Global Markets

  • $ 6650
  • Industry report
  • January 2017
  • by BCC Research

Use this report to: - Examine present and future strategies within the radiopharmaceuticals market, which includes radiopharmaceuticals for both diagnostic purposes and therapeutic purposes. - Learn about ...

Nuclear Imaging Equipment Market by Product, Hybrid PET, Planar Scintigraphy, Application, End user - Global Forecasts to 2021

Nuclear Imaging Equipment Market by Product, Hybrid PET, Planar Scintigraphy, Application, End user - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The nuclear imaging equipment market is projected to reach USD 2.85 billion by 2021 from USD 2.25 billion in 2016, growing at a CAGR of 4.8% in the next five years (2016 to 2021). Over the years, the nuclea ...

Global Nuclear Medicine Market

Global Nuclear Medicine Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global nuclear medicines market is expected to reach USD 17,600 million by the end of 2020, growing at a CAGR of around 12.29% from 2015 to 2020. Nuclear medicine utilizes the radioisotope for application ...

Global Nuclear Imaging Market

December 2016 $ 4250


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.